Abstract
Aims
Cardiac syndrome X (CSX) is characterized by exercise-induced angina, positive exercise stress-test responses and angiographically normal coronary arteries. The condition characteristically affects more women than men and is often associated with coronary microvascular dysfunction, i.e., abnormal vasodilatory responses. Recent clinical observations suggest that increased coronary vasoconstriction may have a pathogenic role in CSX. We therefore sought to assess the prevalence of increased epicardial and microvascular coronary vasoconstriction in women with CSX.
Methods and results
Among 1,120 consecutive women with angina undergoing diagnostic coronary angiography 39 fulfilled criteria for CSX (mean age 63 ± 9 years) and were included in the study (27 also complained about rest angina). Five women without angina (mean age 64 ± 24 years) and normal coronary arteriograms served as controls. Patients and controls underwent intracoronary acetylcholine testing with a standardized protocol. Severe (≥75 % diameter reduction) epicardial constriction developed in 12 CSX patients (31 %) with reproduction of their angina in 10. All 12 patients showed diffuse epicardial constriction affecting mainly the distal coronary segments. Twenty-two CSX patients (56 %) experienced their usual angina without epicardial constriction of which 21 had ischemic ECG shifts. The remaining five CSX patients (13 %) had no angina or constriction in response to acetylcholine. None of the control patients had angina or constriction during ACH testing.
Conclusion
Increased epicardial as well as microvascular coronary constriction in response to acetylcholine are frequent findings in women with CSX. The results indicate that inappropriate coronary constriction is likely to contribute to the anginal symptoms of these patients. The ACH-test may be useful in the clinical setting to unmask this vasomotor disorder.
Similar content being viewed by others
References
Kaski JC (2004) Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 109:568–572
Patel MR, Peterson ED, Dai D et al (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362:886–895
Cannon RO 3rd, Epstein SE (1988) “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 61:1338–1343
Crea F, Lanza GA (2004) Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 90:457–463
Infusino F, Lanza GA, Sestito A et al (2009) Combination of variant and microvascular angina. Clin Cardiol 32:E40–E45
Yilmaz A, Hill S, Schäufele T et al (2010) Exercise-induced spastic coronary artery occlusion at the site of a moderate stenosis: neither Prinzmetal’s angina nor cardiac syndrome X but “Prinzmetal X”. Circulation 122:e570–e574
Kaski JC, Rosano GM, Collins P et al (1995) Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 25:807–814
Lanza GA, Manzoli A, Pasceri V et al (1997) Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing. Am J Cardiol 79:1–6
Ong P, Athanasiadis A, Hill S et al (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 52:523–527
Lüscher TF, Pieper M, Tendera M et al (2009) A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. Eur Heart J 30:1590–1597
Sueda S, Mineoi K, Kondo T et al (1998) Absence of induced spasm by intracoronary injection of 50 micrograms acetylcholine in the right coronary artery: usefulness of 80 micrograms of acetylcholine as a spasm provocation test. J Cardiol 32:155–161
Austen WG, Edwards JE, Frye RL et al (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51(4 Suppl):5–40
Mohri M, Koyanagi M, Egashira K et al (1998) Angina pectoris caused by coronary microvascular spasm. Lancet 351:1165–1169
Sun H, Mohri M, Shimokawa H et al (2002) Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 39:847–851
Levene DL, Freeman MR (1976) Alpha-adrenoceptor-mediated coronary artery spasm. JAMA 236:1018–1022
Specchia G, de Servi S, Falcone C et al (1979) Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation 59:948–954
Waters DD, Szlachcic J, Bonan R et al (1983) Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 67:310–315
Boden WE, Bough EW, Korr KS et al (1981) Exercise-induced coronary spasm with S-T segment depression and normal coronary arteriography. Am J Cardiol 48:193–197
Sacknoff DM, Wilentz JR, Schiffer MB et al (1993) Exercise-induced ST-segment depression: relationship to nonocclusive coronary artery spasm. Am Heart J 125:242–244
Coma-Canella I, Castano S, Macías A et al (2006) Ergonovine test in angina with normal coronary arteries. Is it worth doing it? Int J Cardiol 107:200–206
Lanza GA (2007) Cardiac syndrome X: a critical overview and future perspectives. Heart 93:159–166
Gross L, Epstein EZ, Kugel MA (1934) Histology of the coronary arteries and their branches in the human heart. Am J Pathol 10(253–274):7
Egashira K, Suzuki S, Hirooka Y et al (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25:201–206
Toda N (1983) Isolated human coronary arteries in response to vasoconstrictor substances. Am J Physiol 245:H937–H941
Thorin E (2001) Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol 38:90–98
el-Tamimi H, Mansour M, Wargovich TJ et al (1994) Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited. Circulation 89:45–51
Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, SCAST (Statin and Coronary Artery Spasm Trial) Investigators (2008) Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 51:1742–1748
Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Merz CN, Pepine CJ (2011) In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J 162:678–684
Pizzi C, Manfrini O, Fontana F, Bugiardini R (2004) Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation 109:53–58
Nielsen H, Egeblad H, Mortensen SA et al (1987) Observations on increased susceptibility to coronary artery vasospasm during beta blockade. Am Heart J 114:192–194
Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, Sakuma T, Nagashima K, Kato K (1989) Effect of nicorandil on coronary spasm. Am J Cardiol 63:75J–79J
Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, Bairey Merz CN (2011) Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 4:514–522
Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G, Ellahham S, Quyyumi AA (2002) The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 40:1232–1240
Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO, Lerman A (2010) Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation 122:958–966
Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109:2518–2523
Kaski JC (2002) Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 53:620–626
Vaccarino V, Badimon L, Corti R et al (2011) Ischemic heart disease in women: are there sex differences in pathophysiology and risk factors?: Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 90:9–17
Vermeltfoort IA, Raijmakers PG, Riphagen II, Odekerken DA, Kuijper AF, Zwijnenburg A, Teule GJ (2010) Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol 99:475–481
Acknowledgements
The authors are grateful to nurses and technicians in the catheterization laboratories and to all staff members of the Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany, for their help and support during the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
U. Sechtem and J.C. Kaski contributed equally to this study.
Rights and permissions
About this article
Cite this article
Ong, P., Athanasiadis, A., Mahrholdt, H. et al. Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol 101, 673–681 (2012). https://doi.org/10.1007/s00392-012-0442-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-012-0442-4